Annual EBITDA
-$566.92M$491.34M-650.09%
Summary
- Current Value
- As of today, NUVB annual EBITDA is -$566.92M, down -650.09% on
- Historical Performance
- NUVB annual EBITDA is down -508.71% over the past 3 years, and down -1204.81% over the past 5 years
- All-Time High Comparison
- NUVB annual EBITDA is currently -1204.81% below its historical high of -$43.45M set on
- 3-Year Low Comparison
- NUVB annual EBITDA is at its 3-year low
- Sector Comparison
- NUVB annual EBITDA is higher than 1.19% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$566.92M | -650.1% | -508.7% | -1204.8% | -1204.8% | |
| Quarterly EBITDA | -$55.90M | -16.6% | -92.0% | -385.2% | -507.9% | |
| TTM EBITDA | -$231.55M | -72.9% | -85.8% | -679.5% | -2417.9% | |
| Price | $8.32 | +176.3% | +307.6% | -24.6% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $7.87M | +100.0% | +100.0% | +100.0% | +100.0% | |
| Annual EPS | -$2.11 | -510.2% | -381.4% | -394.8% | -394.8% | |
| Annual EBIT | -$567.60M | -648.8% | -508.2% | -1203.3% | -1203.3% | |
| Annual Net Income | -$567.94M | -649.2% | -554.0% | -1263.3% | -1263.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$75.58M | -650.1% | |
| 5Y | -$43.45M | N/A | -1204.8% |
| All | -$43.45M | -1204.8% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$566.92M | at low | |
| 5Y | -$566.92M | at low | |
| All | -$566.92M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$566.92M | -650.1% | |
| -$75.58M | +36.8% | |
| -$119.54M | -28.3% |
| Year | Value | Change |
|---|---|---|
| -$93.13M | -114.4% | |
| -$43.45M | - |
FAQ
What is the current annual EBITDA of NUVB?
As of today, NUVB annual EBITDA is -$566.92M
What is 1-year change in NUVB annual EBITDA?
NUVB annual EBITDA is down -650.09% year-over-year
What is 3-year change in NUVB annual EBITDA?
NUVB annual EBITDA is down -508.71% over the past 3 years
How far is NUVB annual EBITDA from its all-time high?
NUVB annual EBITDA is currently -1204.81% below its historical high of -$43.45M set on December 31, 2020
How does NUVB annual EBITDA rank versus sector peers?
NUVB annual EBITDA is higher than 1.19% of companies in Healthcare sector
When is NUVB next annual earnings release?
The next annual earnings release for NUVB is on
Quarterly EBITDA
-$55.90M$7.33M+11.60%
Summary
- Current Value
- As of today, NUVB quarterly EBITDA is -$55.90M, up +11.60% on
- Historical Performance
- NUVB quarterly EBITDA is down -16.61% year-over-year, and down -91.96% over the past 3 years
- All-Time High Comparison
- NUVB quarterly EBITDA is currently -521.73% below its historical high of -$8.99M set on
- 3-Year Low Comparison
- NUVB quarterly EBITDA is +11.60% above its 3-year low of -$63.23M reached on
- Sector Comparison
- NUVB quarterly EBITDA is higher than 6.41% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$55.90M | +11.6% | -16.6% | -92.0% | -385.2% | |
| Annual EBITDA | -$566.92M | – | -650.1% | -508.7% | -1204.8% | |
| TTM EBITDA | -$231.55M | -3.6% | -72.9% | -85.8% | -679.5% | |
| Price | $8.32 | +121.7% | +176.3% | +307.6% | -24.6% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $13.12M | +171.5% | +1704.7% | +100.0% | +100.0% | |
| Quarterly EPS | -$0.16 | +5.9% | -8.2% | -30.8% | -70.7% | |
| Quarterly EBIT | -$56.43M | +11.3% | -17.3% | -92.4% | -388.8% | |
| Quarterly Net Income | -$55.79M | +5.5% | -35.4% | -105.1% | -405.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$53.72M | N/A | -4.0% |
| 3Y | -$20.14M | -177.5% | |
| 5Y | -$13.74M | N/A | -306.8% |
| All | -$8.99M | -521.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$63.23M | +11.6% | |
| 3Y | -$63.23M | +11.6% | |
| 5Y | -$63.23M | +11.6% | |
| All | -$63.23M | +11.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of NUVB?
As of today, NUVB quarterly EBITDA is -$55.90M
What is NUVB quarterly EBITDA most recent change?
NUVB quarterly EBITDA was up +11.60% on September 30, 2025
What is 1-year change in NUVB quarterly EBITDA?
NUVB quarterly EBITDA is down -16.61% year-over-year
How far is NUVB quarterly EBITDA from its all-time high?
NUVB quarterly EBITDA is currently -521.73% below its historical high of -$8.99M set on June 1, 2020
How does NUVB quarterly EBITDA rank versus sector peers?
NUVB quarterly EBITDA is higher than 6.41% of companies in Healthcare sector
When is NUVB next earnings release?
The next earnings release for NUVB is on
TTM EBITDA
-$231.55M$7.96M-3.56%
Summary
- Current Value
- As of today, NUVB TTM EBITDA is -$231.55M, down -3.56% on
- Historical Performance
- NUVB TTM EBITDA is down -72.89% year-over-year, and down -85.85% over the past 3 years
- All-Time High Comparison
- NUVB TTM EBITDA is currently -2417.94% below its historical high of -$9.20M set on
- 3-Year Low Comparison
- NUVB TTM EBITDA is at its 3-year low
- Sector Comparison
- NUVB TTM EBITDA is higher than 5.69% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$231.55M | -3.6% | -72.9% | -85.8% | -679.5% | |
| Annual EBITDA | -$566.92M | – | -650.1% | -508.7% | -1204.8% | |
| Quarterly EBITDA | -$55.90M | +11.6% | -16.6% | -92.0% | -385.2% | |
| Price | $8.32 | +121.7% | +176.3% | +307.6% | -24.6% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $26.75M | +86.3% | +1137.2% | +100.0% | +100.0% | |
| TTM EPS | -$0.64 | -2.0% | +70.5% | -26.8% | +38.2% | |
| TTM EBIT | -$232.97M | -3.7% | -73.3% | -86.4% | -682.2% | |
| TTM Net Income | -$217.48M | -7.2% | +59.1% | -100.5% | -666.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$166.87M | N/A | -38.8% |
| 3Y | -$93.29M | -148.2% | |
| 5Y | -$43.45M | N/A | -432.9% |
| All | -$9.20M | -2417.9% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$231.55M | at low | |
| 3Y | -$231.55M | at low | |
| 5Y | -$231.55M | at low | |
| All | -$231.55M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of NUVB?
As of today, NUVB TTM EBITDA is -$231.55M
What is NUVB TTM EBITDA most recent change?
NUVB TTM EBITDA was down -3.56% on September 30, 2025
What is 1-year change in NUVB TTM EBITDA?
NUVB TTM EBITDA is down -72.89% year-over-year
How far is NUVB TTM EBITDA from its all-time high?
NUVB TTM EBITDA is currently -2417.94% below its historical high of -$9.20M set on March 1, 2020
How does NUVB TTM EBITDA rank versus sector peers?
NUVB TTM EBITDA is higher than 5.69% of companies in Healthcare sector
When is NUVB next earnings release?
The next earnings release for NUVB is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- NUVB Official Website www.nuvationbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1811063/000119312525262605/0001193125-25-262605-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1811063/000095017025034903/0000950170-25-034903-index.htm
- NUVB Profile on Yahoo Finance finance.yahoo.com/quote/NUVB
- NUVB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nuvb